Carna Biosciences, Inc. (4572.T) JPX

208.00

+1(+0.48%)

Updated at October 20 10:33AM

Currency In JPY

Valuation

Market Cap5.37B
Enterprise Value3.33B
P/E Ratio-1.86
PEG Ratio-0.22
Price/Sales Ratio6.94
Price/Book Ratio2.86
Enterprise/Revenue5.12
Enterprise/EBITDA-1.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-3.74
Operating Margin-3.55

Management Effectiveness

Return On Assets-1.31
Return On Equity-1.01

Income Statement

Revenue636.24M
Revenue/Share29.96
Gross Profit465.69M
EBITDA-2.14B
Net Income-2.18B
Diluted EPS-121.64

Balance Sheet

Total Cash1.06B
Total Cash/Share55.52
Total Debt18.41M
Total Debt/Equity0.01
Current Ratio8.63
Book Value Per Share72.83

Price History

52-Week Change-37.16
52-Week High376
52-Week Low206
Moving Average 50 Days225.26
Moving Average 200 Days276.62

Statistics

Average Volume208,856
Shares Outstanding19.1M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor100:1
Last Split DateDecember 26, 2013